1-2 of 2
Erik Asmus
Close
Sort by
Journal Articles

Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL

Clinical Trials & Observations
Wei Ding, Betsy R. LaPlant, Timothy G. Call, Sameer A. Parikh, Jose F. Leis, Rong He, Tait D. Shanafelt, Sutapa Sinha, Jennifer Le-Rademacher, Andrew L. Feldman, Thomas M. Habermann, Thomas E. Witzig, Gregory A. Wiseman, Yi Lin, Erik Asmus, Grzegorz S. Nowakowski, Michael J. Conte, Deborah A. Bowen, Casey N. Aitken, Daniel L. Van Dyke, Patricia T. Greipp, Xin Liu, Xiaosheng Wu, Henan Zhang, Charla R. Secreto, Shulan Tian, Esteban Braggio, Linda E. Wellik, Ivana Micallef, David S. Viswanatha, Huihuang Yan, Asher A. Chanan-Khan, Neil E. Kay, Haidong Dong, Stephen M. Ansell
Journal: Blood
Blood (2017) 129 (26): 3419–3427.
https://doi.org/10.1182/blood-2017-02-765685
Published: 2017
Includes: Supplemental data
Journal Articles

PD-1 Blockade with Pembrolizumab in Relapsed CLL Including Richter's Transformation: An Updated Report from a Phase 2 Trial (MC1485)

Wei Ding, MD PhD, Jennifer Le-Rademacher, PhD, Timothy G. Call, MD, Sameer A. Parikh, MD, Jose F. Leis, MD PhD, Tait D. Shanafelt, MD, Rong He, MD, Thomas M. Habermann, MD, Yi Lin, MD PhD, Betsy R. Laplant, MS, Andrew L Feldman, MD, Thomas E. Witzig, MD, Asher A. Chanan-Khan, MD, Erik Asmus, Daniel L. Van Dyke, PhD, Michael J Conte, PA-C, Deborah A. Bowen, APRN, CNP, Sutapa Sinha, PhD, Henan Zhang, MD, Xin Liu, Charla R Secreto, Shulan Tian, Esteban Braggio, PhD, Ivana Micallef, MD, Huihuang Yan, Ph. D, Neil E. Kay, MD, Haidong Dong, MD PhD, Stephen M Ansell, MD, PhD
Journal: Blood
Blood (2016) 128 (22): 4392.
https://doi.org/10.1182/blood.V128.22.4392.4392
Published: 2016